Skip to content
PICO Portalanswers from OpenAlex

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia

PaperCitations, authors & open-access status

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia is a paper indexed in PICO Portal from OpenAlex.

How many citations does Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia have?

PICO Portalcitation count

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia has 1,939 citations in the OpenAlex counts PICO Portal stores.

When was Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia published?

PICO Portalyear

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia has 2007 year in the PICO Portal index.

What is the open-access status of Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia?

PICO Portaloa status

Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia has bronze oa status in the PICO Portal index.

What is the DOI of Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia?

PICO Portaldoi

The DOI for Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia is on the source record.

What is the PMID of Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia?

PICO Portalpmid

The PMID for Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia is on the source record.

What is the OpenAlex record for Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia?

PICO Portalopenalex

The OpenAlex for Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial